Figure 5: Tetralinoleoyl Cardiolipin With Elamipretide Treatment
C. ChatfieldKathryn
C. SparagnaGenevieve
ChauSarah
PhillipsElisabeth K.
V. AmbardekarAmrut
AftabMuhammad
MitchellMax B.
SucharovCarmen C.
MiyamotoShelley D.
StaufferBrian L.
2019
<b>(A)</b> The effect of HF on tetralinoleoyl cardiolipin (mass-to-charge ratio, 1,448) in untreated samples is expressed as a percentage of total cardiolipin. Elamipretide-treated <b>(B)</b> NF hearts or <b>(C)</b> HF hearts showed no changes in tetralinoleoyl cardiolipin. Untreated hearts in <b>B and C</b> are shown with <b>closed circles</b> and <b>treated hearts</b> with open circles. NF, n = 5; HF, n = 10. Abbreviations as in Figure 1.